AAIPharma Expands Central and Eastern European Operations

Wilmington, N.C., November 6, 2007 -- AAIPharma Inc. announced today that it is further expanding its operations in Central and Eastern Europe with the addition of an experienced team in Hungary. The new office is in Budapest and will initially consist of seven staff. AAIPharma already has two other offices in Central and Eastern Europe with established operations in Croatia and Russia. With the recent addition of an office in South Africa, AAIPharma now has operations in 14 countries worldwide. "Central and Eastern Europe is one of most dynamic regions to run clinical trials" said Ludo Reynders. Ph.D., AAIPharma President and CEO. "Hungary with its population of ten million, good hospital infrastructure and the availability of patients is recognised as a key country in this region. As the needs of our biotechnology and pharmaceutical customers to run global clinical trials are ever increasing, it is important that we continue to expand our international presence in key regions such as this to meet these demands". The group in Hungary has therapeutic expertise in the areas of oncology, cardiovascular, respiratory, gastrointestinal and anti-infective clinical trials, along with particular specialist knowledge of paediatric trials. They will provide clinical monitoring, project management and regulatory affairs services across Phase II-IV. About AAIPharma AAIPharma's scientific and professional teams have provided best-in-class product development expertise since 1979. Our business is founded on partnership and delivery of value. We deliver services ranging from a single test to integrated drug development: consulting, preclinical (oncology), pharmaceutical sciences (CMC), clinical trial supplies manufacturing and distribution and Ph I-IV global clinical development. We focus on medical and clinical relevance from well-founded First-in-Man and Proof of Concept packages through delivery of cost and time effective dose-defining and pivotal trials, to post-registration support. For more information on the Company, please visit AAIPharma's website at www.aaipharma.com. Contact: Victoria Winters VP, Business Development, Europe +44 7771 957 740 victoria.winters@aaipharma.com